OPEN END TURBO BULL OPTIONSSCHEIN - ELI LILLY & CO | Real-time BOERSE MUENCHEN 13:41:04 2024-06-27 EDT | ||
| 41.43 EUR | +0.39% |
|
| Current month | +25.40% | ||
| 1 month | +27.06% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 41.43 | +0.39% |
| 24-06-26 | 41.27 | +0.32% |
| 24-06-25 | 41.14 | +1.96% |
| 24-06-24 | 40.35 | +1.64% |
| 24-06-21 | 39.7 | +0.53% |
Real-time BOERSE MUENCHEN
Last update June 27, 2024 at 01:41 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HC76SN |
| ISIN | DE000HC76SN1 |
| Date issued | 2023-06-05 |
| Strike | 460.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.67 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 41.77 € |
|---|---|
| Lowest since issue | 1.34 € |
| Spread | 0.06 € |
| Spread % | 0.14% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Certificates
- Certificat
